Patent · US Active

Humanized anti-EGFL7 antibodies and methods using same

US8404811B2 · kind B2 · utility

4Cited by

57References

23Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Weilan Ye · Foster City, US
Mark S. Dennis · South San Francisco, US
Jill Fredrickson · Sunnyvale, US

Key dates

Filing date	May 7, 2010
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Apr 29, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns antibodies to EGFL7 and the uses of same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.